Drug Discovery & Pharmaceuticals

RSS

New compound inspired by tapeworm drugs shows two-pronged effectiveness against COVID-19

A group of medications long prescribed to treat tapeworm has inspired a compound that shows two-pronged effectiveness against COVID-19 in laboratory studies, according to a new publication appearing online in the journal ACS Infectious Disease.

9 Aug 2021

Open-access database could speed up repurposing of old drugs as new treatments

Researchers have created a new open-access database of information on drug candidates and how they are metabolized by the body, which could help speed up the repurposing of old drugs as new treatments.

3 Aug 2021

Study paves the way to a new drug design concept

Hydrogen peroxide reacts with copper to produce hydroxyl radicals with strong antibacterial properties. However, this requires high copper concentrations because two copper atoms have to come close together, which occurs by chance.

31 Jul 2021

Researchers identify an unexpected effect for already characterized active substances

Every innovative drug starts with the search for an active substance targeting key players in disease-related processes.

23 Jul 2021

A novel method developed for producing new antibiotics to combat resistant bacteria

Researchers at Children's Hospital of Philadelphia have developed a novel method for producing new antibiotics to combat resistant bacteria.

19 Jul 2021

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies

Russian scientists have synthesized chemical compounds that can stop the degeneration of neurons in Alzheimer's, Parkinson's, and other severe brain pathologies. These substances can provide a breakthrough in the treatment of neurodegenerative pathologies.

19 Jul 2021

Scientists identify existing drugs that may inhibit SARS-CoV-2 virus

The COVID-19 pandemic has caused more than 600,000 deaths in the United States since the start of 2020 and more than 4 million globally.

13 Jul 2021

New approach that uses machine learning could transform drug development

Writing in the July 12, 2021 online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.

12 Jul 2021

Scientists discover drug candidates for treating liver fibrosis among pesticides

Skoltech biologists and their colleagues from Koltzov Institute of Developmental Biology, Russia, and the Chemistry Department of Taras Shevchenko University in Ukraine have discovered fairly unlikely drug candidates for treating liver fibrosis and other pathologies -- among pest control chemicals.

8 Jul 2021

Repurposed drugs for COVID-19 treatment identified through virtual screening and cell-based assays

A joint research group from KAIST and Institut Pasteur Korea has identified repurposed drugs for COVID-19 treatment through virtual screening and cell-based assays.

8 Jul 2021

Common anti-coagulant drug could treat emerging variants of SARS-CoV-2

QUT PhD researcher Zachariah Schuurs said the research team had identified a new binding site on the SARS-CoV-2 spike protein.

7 Jul 2021

New screening method tests the effectiveness of drug compounds that 'glue' proteins together

A new screening method that can test the effectiveness of therapeutic molecules designed to 'glue' proteins together in the body has been developed by researchers at the University of Birmingham and the University of Leicester.

7 Jul 2021

Researchers reveal a promising target for designing anti-cancer therapies

Chances are, every one of us has been affected by cancer in one way or another. Unlike some other deadly diseases, cancer can take many forms inside the human body, so learning more about a single enzyme linked to many types of this disease could lead to more effective treatments.

2 Jul 2021

Anti-malarial drug shows promise in the battle against COVID-19

In the "war" that the world has been fighting against COVID-19, scientists have been scanning their arsenals of previously used drugs in hopes of finding any that can be used to treat the disease.

1 Jul 2021

FairJourney Biologics introduces “THE ANTIBODY SERIES” conference

FairJourney Biologics S.A. (FJB), leaders in the discovery and optimization of antibodies, today announced the launch of the “THE ANTIBODY SERIES” - a 1-day conference bringing together top experts in the antibody field to explore the latest innovation within antibody drug discovery.

From FairJourney Biologics S.A. 1 Jul 2021

Drug Discovery & Pharmaceuticals

New compound inspired by tapeworm drugs shows two-pronged effectiveness against COVID-19

Open-access database could speed up repurposing of old drugs as new treatments

Study paves the way to a new drug design concept

Researchers identify an unexpected effect for already characterized active substances

A novel method developed for producing new antibiotics to combat resistant bacteria

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies

Scientists identify existing drugs that may inhibit SARS-CoV-2 virus

New approach that uses machine learning could transform drug development

Scientists discover drug candidates for treating liver fibrosis among pesticides

Repurposed drugs for COVID-19 treatment identified through virtual screening and cell-based assays

Common anti-coagulant drug could treat emerging variants of SARS-CoV-2

New screening method tests the effectiveness of drug compounds that 'glue' proteins together

Researchers reveal a promising target for designing anti-cancer therapies

Anti-malarial drug shows promise in the battle against COVID-19

FairJourney Biologics introduces “THE ANTIBODY SERIES” conference

First demonstration of COVID-19-like response by an essential virus encoded protein by SARS-CoV-2 in vivo

New components for oligonucleotide drugs show safety, efficacy in treating spinal muscular atrophy

Novel approach to molecular drug design paves way for promising bladder cancer therapy

New molecule extracted from the leaves of chestnut tree neutralizes staph bacteria

Sunflower peptide identified as a potential drug for treating abdominal pain

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest Life Science News